PuSH - Publikationsserver des Helmholtz Zentrums München

Three general concepts to improve risk prediction: Good data, wisdom of the crowd, recalibration.

F1000 Res. 5:2671 (2016)
Verlagsversion DOI
Open Access Gold
Creative Commons Lizenzvertrag
In today's information age, the necessary means exist for clinical risk prediction to capitalize on a multitude of data sources, increasing the potential for greater accuracy and improved patient care. Towards this objective, the Prostate Cancer DREAM Challenge posted comprehensive information from three clinical trials recording survival for patients with metastatic castration-resistant prostate cancer treated with first-line docetaxel. A subset of an independent clinical trial was used for interim evaluation of model submissions, providing critical feedback to participating teams for tailoring their models to the desired target. Final submitted models were evaluated and ranked on the independent clinical trial. Our team, called "A Bavarian Dream", utilized many of the common statistical methods for data dimension reduction and summarization during the trial. Three general modeling principles emerged that were deemed helpful for building accurate risk prediction tools and ending up among the winning teams of both sub-challenges. These principles included: first, good data, encompassing the collection of important variables and imputation of missing data; second, wisdom of the crowd, extending beyond the usual model ensemble notion to the inclusion of experts on specific risk ranges; and third, recalibration, entailing transfer learning to the target source. In this study, we illustrate the application and impact of these principles applied to data from the Prostate Cancer DREAM Challenge.
Altmetric
Weitere Metriken?
Tags
Icb_biostatistics
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
e-ISSN 2046-1402
Quellenangaben Band: 5, Heft: , Seiten: , Artikelnummer: 2671 Supplement: ,
Verlag BioMed Central
Verlagsort London
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed